Related references
Note: Only part of the references are listed.The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells
Sarah Ball et al.
PLOS ONE (2011)
Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Li Lin et al.
CANCER RESEARCH (2010)
A Novel Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Activities and Exhibits Potent Growth-Suppressive Activity in Human Cancer Cells
Li Lin et al.
NEOPLASIA (2010)
The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade
Jeffrey S. Scehnet et al.
BLOOD (2009)
Characterization of STAT3 activation and expression in canine and human osteosarcoma
Stacey L. Fossey et al.
BMC CANCER (2009)
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Michael Hedvat et al.
CANCER CELL (2009)
STAT3-Stathmin Interactions Control Microtubule Dynamics in Migrating T-cells
Navin K. Verma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Stat3 promotes directional cell migration by regulating Rac1 activity via its activator βPIX
Terk Shin Teng et al.
JOURNAL OF CELL SCIENCE (2009)
Molecular characterization of the pediatric preclinical testing panel
Geoffrey Neale et al.
CLINICAL CANCER RESEARCH (2008)
STAT3: A critical transcription activator in angiogenesis
Zhong Chen et al.
MEDICINAL RESEARCH REVIEWS (2008)
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program
John M. Maris et al.
PEDIATRIC BLOOD & CANCER (2008)
Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program
John M. Maris et al.
PEDIATRIC BLOOD & CANCER (2008)
The pediatric preclinical testing program: Description of models and early testing results
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2007)
Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells
Chun-Liang Chen et al.
BMC CANCER (2007)
Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3
Wen-Chang Li et al.
CLINICAL CANCER RESEARCH (2006)
STAT3 is activated in a subset of the Ewing sarcoma family of tumours
R Lai et al.
JOURNAL OF PATHOLOGY (2006)
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells
H Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C
TN Dechow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation
Y Yahata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis
DY Wei et al.
ONCOGENE (2003)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart
T Osugi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
